Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 11/20 | 0.43 |
| ▸ | CA2 | P00918 | 11/20 | 0.43 |
| ▸ | CA12 | O43570 | 9/20 | 0.43 |
| ▸ | CA7 | P43166 | 9/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 9/20 | 0.43 |
| ▸ | CA9 | Q16790 | 6/20 | 0.42 |
| ▸ | TBXA2R | P21731 | 8/20 | 0.39 |
| ▸ | PNMT | P11086 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14508405 | 0.79 | CA1 (0.41) | CA1CA2CA12CA7CA14 | |
| SCHEMBL1472801 | 0.78 | CA1 (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL28294086 | 0.78 | CA1 (0.39) | CA1CA2CA12CA7CA14 | |
| SCHEMBL5472752 | 0.77 | CA1 (0.43) | CA1CA2CA12CA7CA14 | |
| SCHEMBL7685050 | 0.76 | ALDH1A1 (0.44) | — | |
| SCHEMBL2250545 | 0.74 | CYP1A2 (0.46) | — | |
| SCHEMBL4914678 | 0.73 | CA1 (0.46) | CA1CA2CA12CA7CA14 | |
| SCHEMBL29519118 | 0.73 | CA1 (0.46) | CA1CA2CA12CA7CA14 | |
| SCHEMBL1971027 | 0.73 | CA1 (0.76) | CA1CA2CA12CA7CA14 | |
| SCHEMBL12365884 | 0.71 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101421258-B | Sulfonyl-substituted bicyclic compounds as PPAR modulators | KALYPSYS INC | 2013-08-21 | — | — | CN | disclosed |
| CN-101421258-A | Sulfonyl-substituted bicyclic compounds as PPAR modulators | KALYSPSYS INC (US) | 2009-04-29 | — | — | CN | disclosed |